More answers like this
Grok 4.5Oct 30, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

The US is better prepared in several key areas than it was before COVID-19 but is not fully ready for another major pandemic or widespread health crisis, according to expert assessments, government reports, and rankings. Significant progress has occurred in stockpiles, surveillance, institutional structures, and medical countermeasures, yet persistent gaps in funding, coordination, leadership, workforce, supply chains, and sustained political commitment leave vulnerabilities. Experts, including the Bipartisan Commission on Biodefense and the Government Accountability Office (GAO), describe the nation as still “dangerously vulnerable” and call for immediate action.[1]

Strengths and Progress Made

The US ranks highest globally on the Global Health Security (GHS) Index (score of 83.5 out of 100, 1st out of 195 countries in the latest available assessment). It scores particularly strongly in prevention (e.g., biosafety, immunization), detection/reporting (laboratory systems, surveillance, epidemiology workforce), and certain response and norms categories, far above global averages.[2]

Key improvements include:

•Strategic National Stockpile (SNS): Dramatically expanded. Pre-COVID levels of N95 respirators were very low (around 12 million); post-pandemic inventories reached hundreds of millions, with reports of 70 times more N95s, 34 times more gloves, 50 times more isolation gowns, and 10 times more ventilators than pre-pandemic. Ventilator holdings grew substantially (from roughly 14,000–20,000 toward 100,000+ range in earlier replenishment phases), with ongoing maintenance and training programs. PPE and other supplies have supported responses to H5N1 and other outbreaks.[3]
•Surveillance and data systems: Major upgrades. Automated electronic case reporting expanded from fewer than 200 healthcare facilities pre-COVID to over 45,000–48,000 by 2024. Wastewater surveillance, syndromic data from most emergency departments, and better genomic sequencing/sharing have improved early warning. CDC has advanced “One CDC” data platforms and lab partnerships (e.g., “warm base” contracts with clinical labs).[4]
•Institutional and policy advances: Creation of the permanent White House Office of Pandemic Preparedness and Response Policy (OPPR). Updates to biodefense strategies, dual-use research oversight, BARDA investments in medical countermeasures (MCMs), and the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE). The Pandemic and All-Hazards Preparedness Act (PAHPA) provides a framework. Billions invested in global health security (over $3 billion since 2020), supporting the Pandemic Fund, vaccine donations (nearly 700 million COVID doses), and responses to mpox, Ebola, and others.[5]
•Manufacturing and innovation: Efforts to onshore production, Project BioShield, mRNA platform investments (including for H5N1), and initiatives for rapid countermeasure development (e.g., 100 Days Mission concepts). Experience from COVID, mpox, and H5N1 has built operational knowledge.
•Response tools: Expanded Health Care Coalitions, Medical Reserve Corps (hundreds of thousands of volunteers), and capabilities for deploying Federal Medical Stations and other assets.

The Biden-Harris Administration’s roadmap (released near the end of the term) highlighted these as building a stronger baseline, including for avian flu (H5N1) monitoring, testing, and vaccine stockpiling (e.g., millions of doses and mRNA development).[6]

Persistent Gaps and Challenges

Despite gains, multiple authoritative sources highlight unfinished business and risks of backsliding:

•Bipartisan Commission on Biodefense (2024 National Blueprint): The nation “remains dangerously vulnerable.” Leadership is fragmented across 15+ departments/agencies without sufficient White House-level sustained authority. Detection systems (e.g., critiques of BioWatch) are inadequate; MCM development funding is insufficient and crisis-dependent; indoor air quality/building protections lag; intelligence, attribution, deterrence, and recovery/mitigation need strengthening. It issued 36 recommendations and 185 action items, urging codification of leadership roles, better One Health approaches, and sustained investment. Apathy and on-again/off-again attention after COVID risk reversing progress.[1]
•GAO findings: HHS leadership and coordination of public health emergencies remain on the High-Risk List. Hundreds of COVID-related recommendations (around half of ~400–450) remained unimplemented as of mid-to-late 2024 (e.g., ~220 open). Long-standing issues include incomplete biosurveillance/situational awareness networks (required by statute for years), unclear roles/responsibilities, exercise monitoring for systemic lessons, workforce planning for responders, MCM manufacturing risks, and supply chain vulnerabilities. Funding and performance measures for stockpiles and readiness need better definition.[7]
•Funding shortfalls: PHEMCE estimated multi-year needs of ~$79.5 billion with large projected gaps if appropriations stay flat. Emergency COVID supplemental funds expired, ending programs like Bridge Access for vaccines and straining public health. Chronic underfunding of core public health infrastructure, workforce shortages (projected physician and other healthcare gaps), and state/local capacity persist.[8]
•Other vulnerabilities: Antimicrobial resistance (AMR); inequitable healthcare access; supply chain fragility (despite onshoring efforts); challenges in animal-human interface (e.g., H5N1 dairy cattle spread has drawn criticism for insufficient testing cooperation, farmer reluctance, and cross-sector coordination); public trust/misinformation issues that complicated COVID response; and limited exercising of plans in some metrics. Healthcare system capacity (beds, staffing) and social determinants can amplify crises. Recent policy shifts, such as US rejection of 2024 WHO International Health Regulations amendments, may affect international coordination.[9]

H5N1 (bird flu) circulating in US cattle and poultry, with human cases (mostly mild among workers), has tested systems and revealed ongoing One Health and agricultural-public health integration needs.[10]

Overall Assessment

The US has stronger tools, stockpiles, data infrastructure, and experience than in 2019–2020, positioning it better than most countries for detection, initial response, and MCM development. It can handle many localized or moderate threats more effectively. However, for a severe, novel, highly transmissible pandemic (or deliberate biothreat) on the scale of or worse than COVID—especially one straining hospitals nationwide, disrupting supply chains further, or occurring amid polarization and fiscal constraints—major shortfalls in sustained funding, unified leadership/coordination, workforce surge capacity, equitable access, and long-term resilience remain.

Preparedness is not a one-time achievement but requires continuous investment, exercises, bipartisan commitment, and addressing root issues like public health underfunding and trust. Reports from the Bipartisan Commission, GAO, CDC testimony, and others consistently urge closing these gaps now rather than waiting for the next crisis. Outcomes will also depend on state/local capacity, private sector partnerships, global cooperation (since pathogens do not respect borders), and political will under current and future administrations.

Citations (10)

  1. 1biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “Experts, including the Bipartisan Commission on Biodefense and the Government Accountability Office (GAO), describe the nation as still “dangerously vulnerable” and call for immediate action.”

  2. 2ghsindex.orgNot yet classified
    https://ghsindex.org/country/united-states/

    Backs: “It scores particularly strongly in prevention (e.g., biosafety, immunization), detection/reporting (laboratory systems, surveillance, epidemiology workforce), and certain response and norms categories, far above global averages.”

  3. 3archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “PPE and other supplies have supported responses to H5N1 and other outbreaks.”

  4. 4cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “CDC has advanced “One CDC” data platforms and lab partnerships (e.g., “warm base” contracts with clinical labs).”

  5. 5ucsb.eduAcademic
    https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report

    Backs: “Billions invested in global health security (over $3 billion since 2020), supporting the Pandemic Fund, vaccine donations (nearly 700 million COVID doses), and responses to mpox, Ebola, and others.”

  6. 6apnews.comNews and mediaquality 1.00
    https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca

    Backs: “The Biden-Harris Administration’s roadmap (released near the end of the term) highlighted these as building a stronger baseline, including for avian flu (H5N1) monitoring, testing, and vaccine stockpiling (e.g., millions of doses and mRNA development).”

  7. 7stimson.orgNonprofits and think tanks
    https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/

    Backs: “Funding and performance measures for stockpiles and readiness need better definition.”

  8. 8center-forward.orgNonprofits and think tanks
    https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/

    Backs: “Chronic underfunding of core public health infrastructure, workforce shortages (projected physician and other healthcare gaps), and state/local capacity persist.”

  9. 9reuters.comNews and mediaquality 1.00
    https://www.reuters.com/legal/litigation/us-rejects-who-pandemic-changes-global-health-rules-2025-07-18/

    Backs: “Recent policy shifts, such as US rejection of 2024 WHO International Health Regulations amendments, may affect international coordination.”

  10. 10statnews.comNews and mediaquality 0.82
    https://www.statnews.com/2024/09/16/h5n1-spread-cow-herds-us-response-who-pandemic-preparedness/

    Backs: “H5N1 (bird flu) circulating in US cattle and poultry, with human cases (mostly mild among workers), has tested systems and revealed ongoing One Health and agricultural-public health integration needs.”